I hope you are correct. I believe you may be right in your assumption. I have always believed that their has been an interested party in the background but that they were waiting for more proof of concept which vrp has now been gathering and perhaps has been doing certain tests during trials that have been at the request of certain interested Pharma. They may have been behind the new nebulised formulation that was 16 times the strength of that previously tried. Another fact is that Claire Poll would be instrumental in negotiating and delivering any deal, takeover or partnership as it is my understanding that this would fall under her remit. Now CP and MW have left us and yet Claire Poll who is paid roughly I believe £50k plus per annum is still on vrp payroll. Why??. Well I am assuming she may be already negotiating with a particular interested pharma and therefore her position cannot be currently relinquished all conjecture of course. Just thinking outside the box and all my opinion only. Good luck to all that RPL554 finds commercialisation in one or many formats of which the latter is most likely.
Science and research didn't do much good did it as the share price plummeted from 18p to just over 1p !!! Let's call it an educated guess then rather than a hope and a prayer !! Good luck anyway.
Just come back from holiday
Think it is the quite before the storm, share price is holding relatively good. Mmmmmmmm ;-)))) , If I was a betting man I would wager very favourable results for RPL554. IF it dropped to 4p in a tree shake (expected) then I may buy a few more.
Hope and a prayer? Hmm. Ill focus more on science and research- good luck anyways ArmyBoy :-)
Not much happening now until the AGM next month. Then of course there is the 554 trial results which will be published in the second half of this year. So from July 1st onwards we will all have to hope and pray for positive results.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.